These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 12637215)

  • 61. [Prevention of neuroleukemia by intrathecal administration of cytosar and methotrexate in acute lymphoblastic leukemia in adults].
    Filatov LB; Konstantinova TS; Shalaev VA
    Ter Arkh; 1999; 71(10):38-40. PubMed ID: 10612172
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis and/or at first relapse: results from the GET-LALA group.
    Reman O; Pigneux A; Huguet F; Vey N; Delannoy A; Fegueux N; de Botton S; Stamatoullas A; Tournilhac O; Buzyn A; Charrin C; Boucheix C; Gabert J; Lhéritier V; Vernant JP; Fière D; Dombret H; Thomas X;
    Leuk Res; 2008 Nov; 32(11):1741-50. PubMed ID: 18508120
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Practice of central nervous system prophylaxis and treatment in acute leukemias in Spain. Prospective registry study.
    Sancho JM; Morgades M; Arranz R; Fernández-Abellán P; Deben G; Alonso N; Blanes M; Rodríguez MJ; Nicolás C; Sánchez E; Fernández de Sevilla A; Conde E; Ribera JM;
    Med Clin (Barc); 2008 Oct; 131(11):401-5. PubMed ID: 18928719
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Long-term survival following radiotherapy and cytarabine chemotherapy for sporadic primary central nervous system lymphoma.
    Pöttgen C; Stuschke M; Stüben G; Schmitz A; Schwechheimer K; Wacker HH; Rauhut F; Kleuker S; Wilhelm H; Grehl S; Fehlings T
    Strahlenther Onkol; 2003 Sep; 179(9):626-32. PubMed ID: 14628129
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Treatment of relapsed central nervous system lymphoma with high-dose methotrexate.
    Plotkin SR; Betensky RA; Hochberg FH; Grossman SA; Lesser GJ; Nabors LB; Chon B; Batchelor TT
    Clin Cancer Res; 2004 Sep; 10(17):5643-6. PubMed ID: 15355887
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Analysis of therapeutic effectiveness in 158 childhood acute lymphoblastic leukemia patients treated with ALL-XH-99 protocol].
    Gu LJ; Li J; Xue HL; Tang JY; Chen J; Zhao HJ; Chen J; Ye H; Wang YP; Pan C
    Zhonghua Xue Ye Xue Za Zhi; 2004 Jan; 25(1):1-4. PubMed ID: 14990066
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Improving outcome through two decades in childhood ALL in the Nordic countries: the impact of high-dose methotrexate in the reduction of CNS irradiation. Nordic Society of Pediatric Haematology and Oncology (NOPHO).
    Gustafsson G; Schmiegelow K; Forestier E; Clausen N; Glomstein A; Jonmundsson G; Mellander L; Mäkipernaa A; Nygaard R; Saarinen-Pihkala UM
    Leukemia; 2000 Dec; 14(12):2267-75. PubMed ID: 11187918
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Intermediate dose methotrexate (IDM) in childhood acute lymphocytic leukaemia in Norway. Report on a national treatment program.
    Moe PJ; Seip M; Finne PH
    Haematologia (Budap); 1981; 14(3):257-63. PubMed ID: 6948760
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Successful treatment without cranial radiotherapy of children receiving intensified chemotherapy for acute lymphoblastic leukaemia: results of the risk-stratified randomized central nervous system treatment trial MRC UKALL XI (ISRC TN 16757172).
    Hill FG; Richards S; Gibson B; Hann I; Lilleyman J; Kinsey S; Mitchell C; Harrison CJ; Eden OB;
    Br J Haematol; 2004 Jan; 124(1):33-46. PubMed ID: 14675406
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Methotrexate-related neurotoxicity in the treatment of childhood acute lymphoblastic leukemia.
    Shuper A; Stark B; Kornreich L; Cohen IJ; Avrahami G; Yaniv I
    Isr Med Assoc J; 2002 Nov; 4(11):1050-3. PubMed ID: 12489505
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Intravitreal methotrexate for treating vitreoretinal lymphoma: 10 years of experience.
    Frenkel S; Hendler K; Siegal T; Shalom E; Pe'er J
    Br J Ophthalmol; 2008 Mar; 92(3):383-8. PubMed ID: 18303160
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Intrathecal methotrexate-induced acute cerebellar syndrome.
    Ferhanoglu B; Ongören S; Ar CM; Uzel B; Forta H; Necioglu D
    Ann Hematol; 2003 Apr; 82(4):241-3. PubMed ID: 12707728
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cerebral glucose metabolism in survivors of childhood acute lymphoblastic leukemia.
    Kähkönen M; Metsähonkala L; Minn H; Utriainen T; Korhonen T; Norvasuo-Heilä MK; Harila-Saari A; Aärimaa T; Suhonen-Polvi H; Ruotsalainen U; Solin O; Salmi TT
    Cancer; 2000 Feb; 88(3):693-700. PubMed ID: 10649265
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Chemotherapy alone as initial treatment for primary CNS lymphoma in patients older than 60 years: a multicenter phase II study (26952) of the European Organization for Research and Treatment of Cancer Brain Tumor Group.
    Hoang-Xuan K; Taillandier L; Chinot O; Soubeyran P; Bogdhan U; Hildebrand J; Frenay M; De Beule N; Delattre JY; Baron B;
    J Clin Oncol; 2003 Jul; 21(14):2726-31. PubMed ID: 12860951
    [TBL] [Abstract][Full Text] [Related]  

  • 75. First isolated extramedullary relapse in children with B-cell precursor acute lymphoblastic leukaemia: results of the Cooprall-97 study.
    Domenech C; Mercier M; Plouvier E; Puraveau M; Bordigoni P; Michel G; Benoit Y; Leverger G; Baruchel A; Bertrand Y
    Eur J Cancer; 2008 Nov; 44(16):2461-9. PubMed ID: 18804997
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Disseminated lymphoblastic lymphoma in children and adolescents: results of the COG A5971 trial: a report from the Children's Oncology Group.
    Termuhlen AM; Smith LM; Perkins SL; Lones M; Finlay JL; Weinstein H; Gross TG; Abromowitch M
    Br J Haematol; 2013 Sep; 162(6):792-801. PubMed ID: 23889312
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Childhood acute lymphoblastic leukemia in Norway 1992-2000].
    Kolmannskog S; Flaegstad T; Helgestad J; Hellebostad M; Zeller B; Glomstein A
    Tidsskr Nor Laegeforen; 2007 May; 127(11):1493-5. PubMed ID: 17551551
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Efficacy of prophylactic additional cranial irradiation and intrathecal chemotherapy for the prevention of CNS relapse after allogeneic hematopoietic SCT for childhood ALL.
    Fukano R; Nishimura M; Ito N; Nakashima K; Kodama Y; Okamura J; Inagaki J
    Pediatr Transplant; 2014 Aug; 18(5):518-23. PubMed ID: 24815062
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Central nervous system prophylaxis with high-dose methotrexate does not give rise to significant electroencephalographic changes in children with acute lymphoblastic leukemia.
    Korinthenberg R; Schneider A; Niemeyer C
    J Child Neurol; 2002 Jun; 17(6):409-12. PubMed ID: 12174959
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Allogeneic stem cell transplantation in children with acute lymphoblastic leukemia after isolated central nervous system relapse: our experiences and review of the literature.
    Yoshihara T; Morimoto A; Kuroda H; Imamura T; Ishida H; Tsunamoto K; Naya M; Hibi S; Todo S; Imashuku S
    Bone Marrow Transplant; 2006 Jan; 37(1):25-31. PubMed ID: 16247416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.